
Home » Japan Approves Gilead’s Remdesivir as COVID-19 Treatment
Japan Approves Gilead’s Remdesivir as COVID-19 Treatment

Japan has approved Gilead’s remdesivir for treatment of COVID-19, making it the first country to officially approve the antiviral drug for the coronavirus.
Gilead filed for fast-track approval of the drug on Monday in Japan, just days after the FDA granted remdesivir an Emergency Use Authorization (EUA) for severe COVID-19 patients in the U.S. Japan’s approval reference the EUA issued by the FDA.
Japanese health officials said the drug will be given to patients with severe COVID-19 symptoms.
Upcoming Events
-
08Sep
-
15Sep
-
20Sep
-
21Sep
-
22Sep
-
11Oct